{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:11:11Z","timestamp":1761513071169},"reference-count":49,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,1]]},"DOI":"10.1210\/jc.2011-2837","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T05:33:16Z","timestamp":1323927196000},"page":"1005-1012","source":"Crossref","is-referenced-by-count":11,"title":["Differential Effects of Raloxifene and Estrogen on Body Composition in Growth Hormone-Replaced Hypopituitary Women"],"prefix":"10.1210","volume":"97","author":[{"given":"Vita","family":"Birzniece","sequence":"first","affiliation":[{"name":"Garvan Institute of Medical Research (V.B., U.J.M., J.G., G.J., N.A., K.K.Y.H.), New South Wales 2010, Australia"},{"name":"Department of Endocrinology (V.B., U.J.M., J.G., G.J., K.K.Y.H.), St. Vincent's Hospital, Sydney, New South Wales 2010, Australia"},{"name":"The University of New South Wales (V.B., N.A., K.K.Y.H.), Sydney, New South Wales 2052, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo J.","family":"Meinhardt","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research (V.B., U.J.M., J.G., G.J., N.A., K.K.Y.H.), New South Wales 2010, Australia"},{"name":"Department of Endocrinology (V.B., U.J.M., J.G., G.J., K.K.Y.H.), St. Vincent's Hospital, Sydney, New South Wales 2010, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Gibney","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research (V.B., U.J.M., J.G., G.J., N.A., K.K.Y.H.), New South Wales 2010, Australia"},{"name":"Department of Endocrinology (V.B., U.J.M., J.G., G.J., K.K.Y.H.), St. Vincent's Hospital, Sydney, New South Wales 2010, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research (V.B., U.J.M., J.G., G.J., N.A., K.K.Y.H.), New South Wales 2010, Australia"},{"name":"Department of Endocrinology (V.B., U.J.M., J.G., G.J., K.K.Y.H.), St. Vincent's Hospital, Sydney, New South Wales 2010, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research (V.B., U.J.M., J.G., G.J., N.A., K.K.Y.H.), New South Wales 2010, Australia"},{"name":"The University of New South Wales (V.B., N.A., K.K.Y.H.), Sydney, New South Wales 2052, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Baxter","sequence":"additional","affiliation":[{"name":"Kolling Institute of Medical Research (R.C.B.), The University of Sydney, Royal North Shore Hospital, Sydney, New South Wales 2065 Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken K. Y.","family":"Ho","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research (V.B., U.J.M., J.G., G.J., N.A., K.K.Y.H.), New South Wales 2010, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113391161700_B1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults.","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113391161700_B2","first-page":"72","article-title":"Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism.","volume":"80","author":"Hoffman","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B3","doi-asserted-by":"crossref","first-page":"E1191","DOI":"10.1152\/ajpendo.2001.281.6.E1191","article-title":"Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women.","volume":"281","author":"Wolthers","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ghir.2007.07.005","article-title":"Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adults.","volume":"18","author":"Burt","year":"2008","journal-title":"Growth Horm IGF Res"},{"key":"key\n\t\t\t\t2019041113391161700_B5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.2008.03302.x","article-title":"Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene.","volume":"70","author":"de Paula","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113391161700_B6","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1359\/jbmr.070205","article-title":"Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.","volume":"22","author":"Snyder","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113391161700_B7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.0.1460187","article-title":"Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults: an 18-month randomised, placebo-controlled, double blinded trial.","volume":"146","author":"Sneppen","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113391161700_B8","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials.","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B9","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1210\/jcem.87.5.8454","article-title":"Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms.","volume":"87","author":"Kehely","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B10","first-page":"1600","article-title":"Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status: 3-year results from the HypoCCS Database.","volume":"87","author":"Attanasio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B11","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","article-title":"A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices.","volume":"86","author":"G\u00f6therstr\u00f6m","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2265.1999.00737.x","article-title":"Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.","volume":"51","author":"Rodr\u00edguez-Arnao","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113391161700_B13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI2773","article-title":"The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.","volume":"102","author":"O'Sullivan","year":"1998","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113391161700_B14","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/jc.2005-0173","article-title":"Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women.","volume":"90","author":"Gibney","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.fertnstert.2004.01.033","article-title":"Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-I and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.","volume":"82","author":"Duschek","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113391161700_B16","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1054\/bjoc.2001.2191","article-title":"Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer.","volume":"85","author":"Torrisi","year":"2001","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2019041113391161700_B17","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.metabol.2006.03.005","article-title":"Effects of raloxifene on lipid and lipoprotein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia.","volume":"55","author":"Dayspring","year":"2006","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113391161700_B18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-005-9145-0","article-title":"Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer.","volume":"98","author":"Johansson","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t2019041113391161700_B19","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1210\/jc.2009-2743","article-title":"Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary women.","volume":"95","author":"Birzniece","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","article-title":"Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia.","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113391161700_B21","doi-asserted-by":"crossref","first-page":"E266","DOI":"10.1152\/ajpendo.00483.2004","article-title":"Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men.","volume":"289","author":"Gibney","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B22","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1172\/JCI112742","article-title":"Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma.","volume":"78","author":"Baxter","year":"1986","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113391161700_B23","doi-asserted-by":"crossref","DOI":"10.1002\/0470854596","volume-title":"Cross-over trials in clinical research","author":"Senn","year":"2002","edition":"2nd ed"},{"key":"key\n\t\t\t\t2019041113391161700_B24","first-page":"55","article-title":"Growth hormone and bone.","volume":"19","author":"Ohlsson","year":"1998","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113391161700_B25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","article-title":"Increased fracture frequency in adult patients with hypopituitarism and GH deficiency.","volume":"137","author":"Ros\u00e9n","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113391161700_B26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","article-title":"The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density.","volume":"16","author":"W\u00fcster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113391161700_B27","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1210\/jc.2004-0054","article-title":"Bone status and fracture prevalence in Russian adults with childhood-onset growth hormone deficiency.","volume":"89","author":"Bouillon","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B28","first-page":"3352","article-title":"Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.","volume":"81","author":"Hansen","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.1.02317","article-title":"Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.","volume":"156","author":"G\u00f6therstr\u00f6m","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113391161700_B30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ghir.2011.01.001","article-title":"Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency.","volume":"21","author":"J\u00f8rgensen","year":"2011","journal-title":"Growth Horm IGF Res"},{"key":"key\n\t\t\t\t2019041113391161700_B31","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.steroids.2005.04.011","article-title":"Changes in RANKL\/OPG\/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene.","volume":"70","author":"Bashir","year":"2005","journal-title":"Steroids"},{"key":"key\n\t\t\t\t2019041113391161700_B32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/09513590701414907","article-title":"Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.","volume":"23","author":"Dane","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t2019041113391161700_B33","doi-asserted-by":"crossref","first-page":"C954","DOI":"10.1152\/ajpcell.00598.2008","article-title":"Perspectives in mammalian IGFBP-3 biology: local vs. systemic action.","volume":"296","author":"Yamada","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"key\n\t\t\t\t2019041113391161700_B34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ghir.2004.02.002","article-title":"Insulin-like growth factor binding protein (IGFBP) signalling.","volume":"14","author":"Ricort","year":"2004","journal-title":"Growth Horm IGF Res"},{"key":"key\n\t\t\t\t2019041113391161700_B35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1210\/jc.2002-020977","article-title":"Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study.","volume":"88","author":"Ueland","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B36","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1359\/jbmr.2003.18.10.1834","article-title":"Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice.","volume":"18","author":"Silha","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113391161700_B37","first-page":"1468","article-title":"Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.","volume":"12","author":"Eng-Wong","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t2019041113391161700_B38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/CS20080382","article-title":"IGF-I\/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome.","volume":"116","author":"Sierra-Johnson","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"key\n\t\t\t\t2019041113391161700_B39","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113391161700_B40","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.277.5331.1508","article-title":"Differential ligand activation of estrogen receptors ER\u03b1 and ER\u03b2 at AP1 sites.","volume":"277","author":"Paech","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041113391161700_B41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/me.2007-0340","article-title":"Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.","volume":"22","author":"Levy","year":"2008","journal-title":"Mol Endocrinol"},{"key":"key\n\t\t\t\t2019041113391161700_B42","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1073\/pnas.0510391103","article-title":"Muscle GLUT4 regulation by estrogen receptors ER\u03b2 and ER\u03b1.","volume":"103","author":"Barros","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113391161700_B43","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1210\/jc.2005-0595","article-title":"Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes.","volume":"90","author":"Chan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B44","doi-asserted-by":"crossref","first-page":"E654","DOI":"10.1152\/ajpendo.90846.2008","article-title":"Inhibition of adipocyte differentiation by insulin-like growth factor binding protein-3.","volume":"296","author":"Chan","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B45","doi-asserted-by":"crossref","first-page":"E937","DOI":"10.1152\/ajpendo.00014.2002","article-title":"Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice.","volume":"283","author":"Silha","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113391161700_B46","first-page":"231","article-title":"Changes of insulin-mediated protein kinases phosphorylation and the expression of IGFBP-3 in skeletal muscle of streptozotocin-diabetic mice.","volume":"8","author":"Grzelkowska-Kowalczyk","year":"2005","journal-title":"Pol J Vet Sci"},{"key":"key\n\t\t\t\t2019041113391161700_B47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1748-1716.2009.02033.x","article-title":"Oestrogen receptor-\u03b1 activation augments post-exercise myoblast proliferation.","volume":"198","author":"Thomas","year":"2010","journal-title":"Acta Physiol (Oxf)"},{"key":"key\n\t\t\t\t2019041113391161700_B48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbrc.2009.08.153","article-title":"Estrogen receptor regulates MyoD gene expression by preventing AP-1-mediated repression.","volume":"389","author":"Pedraza-Alva","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019041113391161700_B49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1748-1716.2009.01997.x","article-title":"Oestradiol and SERM treatments influence oestrogen receptor coregulator gene expression in human skeletal muscle cells.","volume":"197","author":"Dieli-Conwright","year":"2009","journal-title":"Acta Physiol (Oxf)"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/3\/1005\/10416459\/jcem1005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T23:33:40Z","timestamp":1561073620000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/3\/1005\/2536443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2011-2837","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}